Vyome Holdings (HIND) Total Current Liabilities (2015 - 2026)
Vyome Holdings (HIND) posted quarterly Total Current Liabilities of $2.1 million for Q1 2026, down 48.0% year-over-year from $4.1 million in Q1 2025, and down 21.61% quarter-over-quarter from $2.7 million in Q4 2025.
Vyome Holdings (HIND) Total Current Liabilities (2015 - 2026) Analysis & Trends
Vyome Holdings' Total Current Liabilities history runs 12 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 48.0% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (down 48.0% YoY), while the FY2025 annual figure was $2.7 million, down 52.35% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $2.1 million, down from $2.7 million in the prior quarter.
- The five-year high for Total Current Liabilities was $9.2 million in Q2 2022, with the low at $2.1 million in Q1 2026.
- The 5-year median for Total Current Liabilities is $4.1 million (2025), against an average of $5.0 million.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities tumbled 84.78% in 2022, then surged 51.97% in 2024.
- Vyome Holdings' Total Current Liabilities stood at $7.5 million in 2022, then tumbled by 49.51% to $3.8 million in 2023, then soared by 51.97% to $5.7 million in 2024, then slumped by 52.35% to $2.7 million in 2025, then declined by 21.61% to $2.1 million in 2026.
- Business Quant data shows HIND's Total Current Liabilities at $2.1 million in Q1 2026, $2.7 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - | 630.93 Mn |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | 1.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.86 Mn |
| Mar 31, 2026 | 2.14 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Sep 30, 2025 | 3.12 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 4.12 Mn |
| Dec 31, 2024 | 5.74 Mn |
| Sep 30, 2024 | 4.03 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Mar 31, 2024 | 3.52 Mn |
| Dec 31, 2023 | 3.78 Mn |
| Sep 30, 2023 | 4.47 Mn |
| Jun 30, 2023 | 4.40 Mn |
| Mar 31, 2023 | 7.60 Mn |
| Dec 31, 2022 | 7.48 Mn |
| Sep 30, 2022 | 7.53 Mn |
| Jun 30, 2022 | 9.21 Mn |
| Mar 31, 2022 | 8.17 Mn |
| Dec 31, 2021 | 7.53 Mn |
| Sep 30, 2021 | 10.34 Mn |